- Home
- IQST vs NRSN Comparison
IQST vs NRSN Comparison
Compare IQST & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQST
- NRSN
- Stock Information
- Founded
- IQST 2011
- NRSN 2017
- Country
- IQST United States
- NRSN Israel
- Employees
- IQST N/A
- NRSN N/A
- Industry
- IQST
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- IQST
- NRSN Health Care
- Exchange
- IQST NYSE
- NRSN Nasdaq
- Market Cap
- IQST 34.0M
- NRSN 58.8M
- IPO Year
- IQST N/A
- NRSN 2021
- Fundamental
- Price
- IQST $9.85
- NRSN $1.90
- Analyst Decision
- IQST
- NRSN Buy
- Analyst Count
- IQST 0
- NRSN 2
- Target Price
- IQST N/A
- NRSN $14.00
- AVG Volume (30 Days)
- IQST 166.4K
- NRSN 437.8K
- Earning Date
- IQST 08-11-2025
- NRSN 07-11-2025
- Dividend Yield
- IQST N/A
- NRSN N/A
- EPS Growth
- IQST N/A
- NRSN N/A
- EPS
- IQST N/A
- NRSN N/A
- Revenue
- IQST $289,438,380.00
- NRSN N/A
- Revenue This Year
- IQST N/A
- NRSN N/A
- Revenue Next Year
- IQST N/A
- NRSN N/A
- P/E Ratio
- IQST N/A
- NRSN N/A
- Revenue Growth
- IQST 69.01
- NRSN N/A
- 52 Week Low
- IQST $7.47
- NRSN $0.51
- 52 Week High
- IQST $19.00
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- IQST N/A
- NRSN 48.49
- Support Level
- IQST N/A
- NRSN $1.77
- Resistance Level
- IQST N/A
- NRSN $2.35
- Average True Range (ATR)
- IQST 0.00
- NRSN 0.26
- MACD
- IQST 0.00
- NRSN -0.08
- Stochastic Oscillator
- IQST 0.00
- NRSN 16.07
About IQST IQSTEL INC
iQSTEL Inc is a technology company offering a wide array of services to the telecom and Internet industry. The business divisions of the company are Telecommunication including VoIP, SMS, International Fiber-Optic, Proprietary Internet of Things (IoT), and a Proprietary Mobile Portability Blockchain Platform; the Fintech division includes remittances services, top-up services, Master Card Debit Card, a USA Bank Account, and a Mobile App; Electric Vehicles division offers Electric Motorcycles and plans to launch a Mid Speed Car; and the Metaverse division includes Metaverse platform to access products, services, content, entertainment, information, customer support, and more in a virtual 3D interface. Geographically, it derives a majority of its revenue from the USA.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.